Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 9, 2003, Pages 4418-4425

  Modi, Jitu ^a   Patel, Aneeta ^a   Terrell, Richard ^a   Tuttle, R Michael ^b   Francis, Gary L ^a,c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; KI 67 ANTIGEN;

ADULT; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CELL TYPE; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; THYROID CARCINOMA;

ADOLESCENT; ADULT; ANTIBODY FORMATION; ANTIGENS, CD19; ANTIGENS, CD56; CARCINOMA, PAPILLARY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTES; LYMPHOKINES; MALE; NEOPLASM RECURRENCE, LOCAL; THYROID NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0141564544     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030342     Document Type: Article

References (44)

1. Amino N, Pysher T, Cohen EP, Degroot LJ 1975 Immunologic aspects of human thyroid cancer. Humoral and cell-mediated immunity, and a trial of immunotherapy. Cancer 36:963-973
2. Bershtein LM, Poroshina TE, Tsyrlina EV, Gamaiunova VB, Kovalenko IG, Iurin AG, Evtushenko TP, Larionov AA, Zimarina TS, Ivanova OA, Semiglazov VF 1996 [Correlation of lymphocytic infiltration of tumor tissue with the hormonal and metabolic state in patients with breast cancer]. Vopr Onkol 42:36-39
3. Costa A, de Filippis V, Balsamo A, Ravarino N, Testori O, Torchio B, Valmaggia P, Zoppetti G 1984 Serum autoantibodies and thyroid lymphocytic infiltration in endemic goitre. Clin Exp Immunol 56:143-148
4. Davies TF, Martin A, Concepcion ES, Graves P, Lahat N, Cohen WL, Ben-Nun A 1992 Evidence for selective accumulation of intrathyroidal T lymphocytes in human autoimmune thyroid disease based on T cell receptor V gene usage. J Clin Invest 89:157-162
5. Gomez Saez JM, Gomez Arnaiz N, Sahun de la Vega M, Soler Ramon J 1997 [Prevalence and significance of lymphocyte infiltration in papillary carcinoma of the thyroid gland]. An Med Interna 14:403-405
6. Gupta S, Patel A, Folstad A, Fenton C, Dinauer CA, Tuttle RM, Conran R, Francis GL 2001 Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. J Clin Endocrinol Metab 86:1346-1354
7. Juhasz F, Boros P, Szegedi G, Balazs G, Suranyi P, Kraszits E, Stenszky V, Farid NR 1989 Immunogenetic and immunologic studies of differentiated thyroid cancer. Cancer 63:1318-1326
8. Kamma H, Fujii K, Ogata T 1988 Lymphocytic infiltration in juvenile thyroid carcinoma. Cancer 62:1988-1993
9. Knoll MR, Teuber J, Zmierczak H, Winter J, Usadel KH 1992 Immunologic findings in tissue of thyroid carcinoma. Cancer Detect Prev 16:149-153
10. Kornfehl J, Wilfing A, Hermann M 1994 [Immunohistochemical studies of mononuclear cellular infiltrates of papillary, follicular and anaplastic thyroid cancers]. Laryngorhinootologie 73:183-188
11. Mancini A, Rabitti C, Conte G, Gullotta G, De Marinis L 1993 [Lymphocytic infiltration in thyroid neoplasms. Preliminary prognostic assessments]. Minerva Chir 48:1283-1288
12. Misaki T, Watanabe Y, Iida Y, Hidaka A, Kasagi K, Fukushima H, Konishi J 1992 Recruitment of T lymphocytes and induction of tumor necrosis factor in thyroid cancer by a local immunotherapy. Cancer Immunol Immunother 35:92-96
13. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR 1995 Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 76:2312-2318
14. Patel A, Fenton C, Dogra S, Tuttle RM, Francis GL, Infiltration of childhood thyroid carcinoma by proliferating lymphocytes is associated with increased expression of the FAS receptor and the bax pro-apoptotic peptide. Program of the 84th Annual Meeting of The Endocrine Society, San Francisco, CA, 2002, p 377 (Abstract P2-240)
15. Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP 1999 Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84:458-463
16. Ozaki O, Ito K, Mimura T, Sugino K, Hosoda Y 1996 Papillary carcinoma of the thyroid. Tall-cell variant with extensive lymphocyte infiltration. Am J Surg Pathol 20:695-698
17. Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, Matsuzuka F, Kakudoh K, Kuma K, Tamai H 1995 The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 80:3421-3424
18. McClellan DR, Francis GL 1996 Thyroid cancer in children, pregnant women, and patients with Graves' disease. Endocrinol Metab Clin North Am 25:27-48
19. Welch Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Svec RL, Adair C, Francis GL 1998 Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf) 49:619-628
20. Shah R, Banks K, Patel A, Dogra S, Terrell R, Powers PA, Fenton C, Dinauer CA, Tuttle RM, Francis GL 2002 Intense expression of the b7-2 antigen presentation coactivator is an unfavorable prognostic indicator for differentiated thyroid carcinoma of children and adolescents. J Clin Endocrinol Metab 87:4391-4397
21. Matsuoka N, Eguchi K, Kawakami A, Tsuboi M, Nakamura H, Kimura H, Ishikawa N, Ito K, Nagataki S 1996 Lack of B7-1/BB1 and B7-2/B70 expression on thyrocytes of patients with Graves' disease. Delivery of costimulatory signals from bystander professional antigen-presenting cells. J Clin Endocrinol Metab 81:4137-4143
22. Lucas-Martin A, Foz-Sala M, Todd I, Bottazzo GF, Pujol-Borrell R 1988 Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies. J Clin Endocrinol Metab 66:367-375
23. Weetman AP 1997 New aspects of thyroid immunity. Horm Res 48:51-54
24. Wu Z, Biro PA, Mirakian R, Hammond L, Curcio F, Ambesi-Impiombato FS, Bottazzo GF 1999 HLA-DMB expression by thyrocytes: indication of the antigen-processing and possible presenting capability of thyroid cells. Clin Exp Immunol 116:62-69
25. Lahat N, Rahat MA, Sadeh O, Kinarty AZ 1998 Regulation of HLA-DR and costimulatory B7 molecule. Kraiems in human thyroid carcinoma cells: differential binding of transcription factors to the HLA-DRá promoter. Thyroid 8:361-369
26. DeGroot LJ, Kaplan EL, McCormick M, Straus FH 1990 Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424
27. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS 1993 Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1057; discussion 1057-1058
28. Patel A, Fenton C, Ramirez R, Dinauer CA, Tuttle RM, Nikiforov YE, Francis GL 2000 Tyrosine kinase expression is increased in papillary thyroid carcinoma of children and young adults. Front Biosci 5:A1-A9
29. Patel A, Jhiang S, Dogra S, Terrell R, Powers PA, Fenton C, Dinauer CA, Tuttle RM, Francis GL 2002 Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents. Pediatr Res 52:737-744
30. Patel A, Fenton C, Terrell R, Powers PA, Dinauer C, Tuttle RM, Francis GL 2002 Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents. J Endocrinol Invest 25:675-683
31. Patel A, Straight AM, Mann H, Duffy E, Fenton C, Dinauer C, Tuttle RM, Francis GL 2002 Matrix metalloproteinase (MMP) expression by differentiated thyroid carcinoma of children and adolescents. J Endocrinol Invest 25:403-408
32. Welch Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Francis GL 1999 Extensive surgery improves recurrence-free survival for children and young patients with class I papillary thyroid carcinoma. J Pediatr Surg 34:1799-1804
33. Straight A, Patel A, Fenton C, Dianuer C, Tuttle RM, Francis G 2002 Thyroid carcinomas that express telomerase follow a more aggressive clinical course for children and adolescents. J Endocrinol Invest 25:302-308
34. Mazzaferri EL, Kloos RT 2002 Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab 87:1490-1498
35. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M 2000 Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 85:175-178
36. Hung W, Sarlis NJ 2002 Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid 12:683-702
37. Robbins RJ, Chon JT, Fleisher M, Larson SM, Tuttle RM 2002 Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? J Clin Endocrinol Metab 87:3242-3247
38. Fenton C, Patel A, Dinauer C, Robie DK, Tuttle RM, Francis GL 2000 The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults. Thyroid 10:349-357
39. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G 2003 Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203-213
40. Brizzi MF, Formato L, Dentelli P, Rosso A, Pavan M, Garbarino G, Pegoraro M, Camussi G, Pegoraro L 2001 Interleukin-3 stimulates migration and proliferation of vascular smooth muscle cells: a potential role in atherogenesis. Circulation 103:549-554
41. Jung Y, Isaacs JS, Lee S, Trepel J, Liu ZG, Neckers L 2003 Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor κB activation. Biochem J 370:1011-1017
42. Kim KJ, Li B, Houck K, Winer J, Ferrara N 1992 The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 7:53-64
43. Feletou M, Staczek J, Duhault J 2001 Vascular endothelial growth factor and the in vivo increase in plasma extravasation in the hamster cheek pouch. Br J Pharmacol 132:1342-1348
44. Lee TH, Avraham H, Lee SH, Avraham S 2002 Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J Biol Chem 277:10445-10451